1 | A bill to be entitled |
2 | An act relating to the drug testing of potential and |
3 | existing beneficiaries of unemployment compensation; |
4 | creating s. 443.093, F.S.; creating the Drug Deterrence |
5 | Program within the Agency for Workforce Innovation; |
6 | providing legislative intent; providing the scope of |
7 | eligibility for benefits; defining terms; providing for |
8 | the screening of individuals to determine which |
9 | individuals must be tested; providing for notice; |
10 | providing terms of disqualification for benefits; |
11 | requiring the agency to supply information concerning drug |
12 | treatment programs; providing for authentication and the |
13 | admissibility of drug tests in unemployment compensation |
14 | hearings; creating a rebuttable presumption of drug use |
15 | under certain circumstances; providing testing procedures; |
16 | providing for the preservation of test samples; providing |
17 | for the retesting of test samples; providing for an |
18 | appeals process; authorizing the agency to adopt rules; |
19 | directing the agency to submit a report to the Governor |
20 | and Legislature; directing the Office of Program Policy |
21 | Analysis and Government Accountability to submit a report |
22 | to the Governor and Legislature; providing an effective |
23 | date. |
24 |
|
25 | Be It Enacted by the Legislature of the State of Florida: |
26 |
|
27 | Section 1. Section 443.093, Florida Statutes, is created |
28 | to read: |
29 | 443.093 Drug Deterrence Program.- |
30 | (1) PURPOSE.-It is the intent of the Legislature to create |
31 | within the Agency for Workforce Innovation the Drug Deterrence |
32 | Program. The Legislature finds that illegal drug use is a threat |
33 | to public safety. The purpose of this program is to require the |
34 | drug testing of certain individuals as a condition for |
35 | unemployment benefits in order to prevent the enabling of drug |
36 | use with government funds, thereby protecting the public. |
37 | (2) SCOPE.-In addition to any benefit eligibility or |
38 | disqualification conditions prescribed in this chapter, any |
39 | individual making a claim for benefits or receiving benefits is |
40 | subject to this section. As a condition to making a claim for |
41 | benefits or accepting receipt of benefits, an individual must |
42 | agree to comply with the terms of this section, including, but |
43 | not limited to, agreeing to be subject to drug testing at the |
44 | individual's expense. |
45 | (3) DEFINITIONS.-As used in this section, the term: |
46 | (a) "Agency" means the Agency for Workforce Innovation. |
47 | (b) "Drug" means an amphetamine, a cannabinoid, cocaine, |
48 | phencyclidine (PCP), a hallucinogen, methaqualone, an opiate, a |
49 | barbiturate, a benzodiazepine, a synthetic narcotic, a designer |
50 | drug, or a metabolite of any of the substances listed in this |
51 | paragraph. |
52 | (c) "Drug test" or "test" means any chemical, biological, |
53 | or physical instrumental analysis for the purpose of determining |
54 | the presence or absence of a drug or its metabolites. |
55 | (4) CREATION.- |
56 | (a) The Agency for Workforce Innovation shall implement an |
57 | unemployment compensation drug testing program no later than |
58 | October 1, 2011. |
59 | (b) In creating and implementing the program, the agency |
60 | shall: |
61 | 1. Develop a screening mechanism by which to assess |
62 | whether a person is likely to be an illicit drug user; |
63 | 2. Drug test individuals who are assessed to be likely |
64 | illicit drug users; |
65 | 3. Make a determination of eligibility under s. 443.091 and |
66 | disqualification under s. 443.101 before an applicant is |
67 | selected for drug testing; |
68 | 4. Provide notice of the potential for drug testing to |
69 | individuals claiming and receiving benefits; and |
70 | 5. Require an individual who is to be tested to sign an |
71 | acknowledgement that he or she has received notice of the |
72 | agency's drug testing policy and that he or she has a right to |
73 | refuse to take the drug test. |
74 | (5) TESTING; USE OF RESULTS.- |
75 | (a) An individual is disqualified from receiving or |
76 | continuing to receive benefits upon: |
77 | 1. Refusing to submit to testing under this section; or |
78 | 2. Upon testing positive for drugs as a result of a test |
79 | under this section. |
80 | (b) If the individual fails the drug test required under |
81 | this section, the individual is entitled to only 5 percent of |
82 | his or her unemployment benefits for up to 52 weeks, under rules |
83 | adopted by the agency, and until he or she has earned income of |
84 | at least 17 times his or her weekly benefit amount. |
85 | (c) The agency shall provide any individual who tests |
86 | positive with information concerning drug treatment programs |
87 | that may be available in the area in which he or she resides; |
88 | however, the agency or the state is not responsible for |
89 | providing or paying for drug treatment as part of the testing |
90 | conducted under this section. |
91 | (6) TESTING.- |
92 | (a) All specimen collection and testing for drugs under |
93 | this section must be performed in accordance with the following |
94 | procedures: |
95 | 1. A sample shall be collected with due regard to the |
96 | privacy of the individual providing the sample, and in a manner |
97 | reasonably calculated to prevent substitution or contamination |
98 | of the sample. |
99 | 2. Specimen collection must be documented, and the |
100 | documentation procedures must include: |
101 | a. Labeling of specimen containers so as to reasonably |
102 | preclude the likelihood of erroneous identification of test |
103 | results. |
104 | b. A form for the person being tested to provide any |
105 | information he or she considers relevant to the test, including |
106 | identification of currently or recently used prescription or |
107 | nonprescription medication or other relevant medical |
108 | information. The form must provide notice of the most common |
109 | medications by brand name or common name, as applicable, as well |
110 | as by chemical name, which may alter or affect a drug test. The |
111 | providing of information does not preclude the administration of |
112 | the drug test, but must be taken into account in interpreting |
113 | any positive, confirmed test result. |
114 |
|
115 | Specimen collection, storage, and transportation to the testing |
116 | site must be performed in a manner that reasonably precludes |
117 | contamination or adulteration of specimens. |
118 | (b) Every specimen that produces a positive test result |
119 | must be preserved for at least 6 months. However, if the tested |
120 | person undertakes an administrative or legal challenge to the |
121 | test result, the sample shall be preserved until the case or |
122 | administrative appeal is settled. |
123 | (c) An individual who tests positive for drugs may refute |
124 | and rule out a false positive test by having the same sample |
125 | retested by gas chromatography with mass spectrometry, gas |
126 | chromatography, high performance liquid chromatography, or an |
127 | equally or more specific test. |
128 | (d) Test results and chain-of-custody documentation |
129 | provided to the agency by an approved drug-testing laboratory is |
130 | self-authenticating and admissible in unemployment compensation |
131 | hearings, and such evidence creates a rebuttable presumption |
132 | that the individual used, or was using, drugs. |
133 | (7) APPEAL.-Any person who is deemed ineligible for, or is |
134 | disqualified from, receiving unemployment benefits because of a |
135 | positive drug test has a right to appeal the agency's decision |
136 | pursuant to s. 443.151(4). |
137 | (8) RULES.-The agency shall adopt rules under ss. |
138 | 120.536(1) and 120.54 to administer this section. |
139 | (9) REPORT.- |
140 | (a) The agency shall submit a report to the Governor, the |
141 | President of the Senate, and the Speaker of the House of |
142 | Representatives by January 1, 2013, which at a minimum: |
143 | 1. Gives the number of individuals tested, the substances |
144 | tested for, and the results of the testing; |
145 | 2. Gives the number of individuals denied unemployment |
146 | compensation benefits for failing a drug test upon claiming |
147 | benefits and the number of individuals for whom benefits were |
148 | terminated for failing a test while receiving benefits; |
149 | 3. Describes any obstacles to implementation of the |
150 | program; |
151 | 4. Gives the number of applicants who refused to be |
152 | tested; |
153 | 5. Gives the number of weeks and the amount of benefits |
154 | for which individuals would have been eligible if they had not |
155 | tested positive or refused to take the test; |
156 | 6. Estimates the costs of the drug testing program, |
157 | including the average cost of individual tests and the cost of |
158 | administering the program; |
159 | 7. Estimates savings, if any, under the program to the |
160 | Unemployment Compensation Trust Fund; and |
161 | 8. Includes a recommendation on whether the Legislature |
162 | should maintain the program. |
163 | (b) Before the 2013 Regular Session of the Legislature, |
164 | the Office of Program Policy Analysis and Government |
165 | Accountability shall review and evaluate the Drug Deterrence |
166 | Program and submit a report to the Governor, the President of |
167 | the Senate, and the Speaker of the House of Representatives. The |
168 | report must evaluate whether the program is cost-effective and |
169 | deters drug users from receiving benefits and make a |
170 | recommendation to the Legislature to abolish, continue, |
171 | reorganize, or expand the program. |
172 | Section 2. This act shall take effect July 1, 2011. |